| Product Code: ETC7733775 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Cannabis Pharmaceutical Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Cannabis Pharmaceutical Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Cannabis Pharmaceutical Market - Industry Life Cycle |
3.4 Japan Cannabis Pharmaceutical Market - Porter's Five Forces |
3.5 Japan Cannabis Pharmaceutical Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Japan Cannabis Pharmaceutical Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.7 Japan Cannabis Pharmaceutical Market Revenues & Volume Share, By Compound Type, 2021 & 2031F |
3.8 Japan Cannabis Pharmaceutical Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Japan Cannabis Pharmaceutical Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Japan Cannabis Pharmaceutical Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Japan Cannabis Pharmaceutical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing acceptance of medical cannabis in Japan |
4.2.2 Rising prevalence of chronic diseases and conditions that can be treated with cannabis pharmaceuticals |
4.2.3 Government initiatives to promote research and development in the cannabis pharmaceutical sector |
4.3 Market Restraints |
4.3.1 Stringent regulatory environment surrounding cannabis in Japan |
4.3.2 Limited awareness and education about the benefits of cannabis pharmaceuticals among healthcare professionals and patients |
5 Japan Cannabis Pharmaceutical Market Trends |
6 Japan Cannabis Pharmaceutical Market, By Types |
6.1 Japan Cannabis Pharmaceutical Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Cannabis Pharmaceutical Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Japan Cannabis Pharmaceutical Market Revenues & Volume, By Capsules, 2021- 2031F |
6.1.4 Japan Cannabis Pharmaceutical Market Revenues & Volume, By Concentrates, 2021- 2031F |
6.1.5 Japan Cannabis Pharmaceutical Market Revenues & Volume, By Edibles, 2021- 2031F |
6.2 Japan Cannabis Pharmaceutical Market, By Drugs |
6.2.1 Overview and Analysis |
6.2.2 Japan Cannabis Pharmaceutical Market Revenues & Volume, By Epidiolex, 2021- 2031F |
6.2.3 Japan Cannabis Pharmaceutical Market Revenues & Volume, By Marinol, 2021- 2031F |
6.2.4 Japan Cannabis Pharmaceutical Market Revenues & Volume, By Cesamet, 2021- 2031F |
6.2.5 Japan Cannabis Pharmaceutical Market Revenues & Volume, By Sativex, 2021- 2031F |
6.3 Japan Cannabis Pharmaceutical Market, By Compound Type |
6.3.1 Overview and Analysis |
6.3.2 Japan Cannabis Pharmaceutical Market Revenues & Volume, By Tetrahydrocannabinol (THC), 2021- 2031F |
6.3.3 Japan Cannabis Pharmaceutical Market Revenues & Volume, By Cannabidiol (CBD), 2021- 2031F |
6.3.4 Japan Cannabis Pharmaceutical Market Revenues & Volume, By Balanced THC & CBD, 2021- 2031F |
6.4 Japan Cannabis Pharmaceutical Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Japan Cannabis Pharmaceutical Market Revenues & Volume, By Inflammation, 2021- 2031F |
6.4.3 Japan Cannabis Pharmaceutical Market Revenues & Volume, By Chronic Pain, 2021- 2031F |
6.4.4 Japan Cannabis Pharmaceutical Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.4.5 Japan Cannabis Pharmaceutical Market Revenues & Volume, By Sleep Disorders, 2021- 2031F |
6.4.6 Japan Cannabis Pharmaceutical Market Revenues & Volume, By Anorexia, 2021- 2031F |
6.4.7 Japan Cannabis Pharmaceutical Market Revenues & Volume, By Schizophrenia, 2021- 2031F |
6.5 Japan Cannabis Pharmaceutical Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Japan Cannabis Pharmaceutical Market Revenues & Volume, By Clinic, 2021- 2031F |
6.5.3 Japan Cannabis Pharmaceutical Market Revenues & Volume, By Hospital, 2021- 2031F |
6.6 Japan Cannabis Pharmaceutical Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Japan Cannabis Pharmaceutical Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Japan Cannabis Pharmaceutical Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Japan Cannabis Pharmaceutical Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Japan Cannabis Pharmaceutical Market Import-Export Trade Statistics |
7.1 Japan Cannabis Pharmaceutical Market Export to Major Countries |
7.2 Japan Cannabis Pharmaceutical Market Imports from Major Countries |
8 Japan Cannabis Pharmaceutical Market Key Performance Indicators |
8.1 Number of clinical trials conducted for cannabis pharmaceuticals in Japan |
8.2 Amount of funding allocated by the government for cannabis pharmaceutical research |
8.3 Adoption rate of cannabis pharmaceuticals by healthcare institutions in Japan |
9 Japan Cannabis Pharmaceutical Market - Opportunity Assessment |
9.1 Japan Cannabis Pharmaceutical Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Japan Cannabis Pharmaceutical Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.3 Japan Cannabis Pharmaceutical Market Opportunity Assessment, By Compound Type, 2021 & 2031F |
9.4 Japan Cannabis Pharmaceutical Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 Japan Cannabis Pharmaceutical Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Japan Cannabis Pharmaceutical Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Japan Cannabis Pharmaceutical Market - Competitive Landscape |
10.1 Japan Cannabis Pharmaceutical Market Revenue Share, By Companies, 2024 |
10.2 Japan Cannabis Pharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here